242 related articles for article (PubMed ID: 37798902)
21. Fabrication of Biomaterials and Biostructures Based On Microfluidic Manipulation.
Zheng W; Xie R; Liang X; Liang Q
Small; 2022 Apr; 18(16):e2105867. PubMed ID: 35072338
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in Organ-on-Chips Integrated with Bioprinting Technologies for Drug Screening.
Tabatabaei Rezaei N; Kumar H; Liu H; Lee SS; Park SS; Kim K
Adv Healthc Mater; 2023 Aug; 12(20):e2203172. PubMed ID: 36971091
[TBL] [Abstract][Full Text] [Related]
23. 4D Bioprinting: Technological Advances in Biofabrication.
Yang GH; Yeo M; Koo YW; Kim GH
Macromol Biosci; 2019 May; 19(5):e1800441. PubMed ID: 30821919
[TBL] [Abstract][Full Text] [Related]
24. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
25. Biomaterial-based 3D bioprinting strategy for orthopedic tissue engineering.
Chae S; Cho DW
Acta Biomater; 2023 Jan; 156():4-20. PubMed ID: 35963520
[TBL] [Abstract][Full Text] [Related]
26. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
Wang YI; Carmona C; Hickman JJ; Shuler ML
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
[TBL] [Abstract][Full Text] [Related]
27. 3D printing of functional biomaterials for tissue engineering.
Zhu W; Ma X; Gou M; Mei D; Zhang K; Chen S
Curr Opin Biotechnol; 2016 Aug; 40():103-112. PubMed ID: 27043763
[TBL] [Abstract][Full Text] [Related]
28. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
29. Next generation human skin constructs as advanced tools for drug development.
Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
[TBL] [Abstract][Full Text] [Related]
30. Recent Trends in Decellularized Extracellular Matrix Bioinks for 3D Printing: An Updated Review.
Dzobo K; Motaung KSCM; Adesida A
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540457
[TBL] [Abstract][Full Text] [Related]
31. Emerging Biofabrication Strategies for Engineering Complex Tissue Constructs.
Pedde RD; Mirani B; Navaei A; Styan T; Wong S; Mehrali M; Thakur A; Mohtaram NK; Bayati A; Dolatshahi-Pirouz A; Nikkhah M; Willerth SM; Akbari M
Adv Mater; 2017 May; 29(19):. PubMed ID: 28370405
[TBL] [Abstract][Full Text] [Related]
32. The relevance and potential roles of microphysiological systems in biology and medicine.
Wikswo JP
Exp Biol Med (Maywood); 2014 Sep; 239(9):1061-72. PubMed ID: 25187571
[TBL] [Abstract][Full Text] [Related]
33. Strategies to use fibrinogen as bioink for 3D bioprinting fibrin-based soft and hard tissues.
de Melo BAG; Jodat YA; Cruz EM; Benincasa JC; Shin SR; Porcionatto MA
Acta Biomater; 2020 Nov; 117():60-76. PubMed ID: 32949823
[TBL] [Abstract][Full Text] [Related]
34. Embedded bioprinting for designer 3D tissue constructs with complex structural organization.
Zeng X; Meng Z; He J; Mao M; Li X; Chen P; Fan J; Li D
Acta Biomater; 2022 Mar; 140():1-22. PubMed ID: 34875360
[TBL] [Abstract][Full Text] [Related]
35. A dive into the bath: embedded 3D bioprinting of freeform
Öztürk-Öncel MÖ; Leal-Martínez BH; Monteiro RF; Gomes ME; Domingues RMA
Biomater Sci; 2023 Aug; 11(16):5462-5473. PubMed ID: 37489648
[TBL] [Abstract][Full Text] [Related]
36. High-throughput screening approaches and combinatorial development of biomaterials using microfluidics.
Barata D; van Blitterswijk C; Habibovic P
Acta Biomater; 2016 Apr; 34():1-20. PubMed ID: 26361719
[TBL] [Abstract][Full Text] [Related]
37. Decellularized Extracellular Matrix-based Bioinks for Engineering Tissue- and Organ-specific Microenvironments.
Kim BS; Das S; Jang J; Cho DW
Chem Rev; 2020 Oct; 120(19):10608-10661. PubMed ID: 32786425
[TBL] [Abstract][Full Text] [Related]
38. Biofabrication of vasculature in microphysiological models of bone.
Whelan IT; Moeendarbary E; Hoey DA; Kelly DJ
Biofabrication; 2021 Jul; 13(3):. PubMed ID: 34034238
[TBL] [Abstract][Full Text] [Related]
39. Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma.
DePalma TJ; Sivakumar H; Skardal A
Adv Drug Deliv Rev; 2022 Jan; 180():114067. PubMed ID: 34822927
[TBL] [Abstract][Full Text] [Related]
40. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
